Reduction of human menopausal gonadotropin dose before coasting prevents severe ovarian hyperstimulation syndrome with minimal cycle cancellation
- PMID: 10976419
- PMCID: PMC3455203
- DOI: 10.1023/a:1009470602525
Reduction of human menopausal gonadotropin dose before coasting prevents severe ovarian hyperstimulation syndrome with minimal cycle cancellation
References
-
- Rizk B, Aboulghar M. Modern management of ovarian hyperstimulation syndrome. Hum Reprod. 1991;6:1082–1087. - PubMed
-
- Schenker JG, Weinstein D. Ovarian hyperstimulation syndrome: A current survey. Fertil Steril. 1978;30:255–268. - PubMed
-
- Aboulghar MA, Mansour RT, Serour GI, Sattar M, Amin Y, El-Attar I. Management of severe ovarian hyperstimulation syndrome by ascitic fluid aspiration and intensive fluid therapy. Obstet Gynecol. 1993;81:108–111. - PubMed
-
- Benadivia CA, Davis O, Kligman I, Moomjy M, Liu H-C, Rosenwaks Z. Withholding gonadotropin administration is an effective alternative for the prevention of ovarian hyperstimulation syndrome. Fertil Steril. 1997;67:724–727. - PubMed
-
- Sher G, Salem R, Feinman M, Dodge S, Zouves C, Knutzen V. Eliminating the risk of life-endangering complications following overstimulation with menotropin fertility agents: A report on women undergoing in vitro fertilization and embryo transfer. Obstet Gynecol. 1993;81:1009–1011. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical